CAR T-cell therapy modifies T cells to target cancer, showing promise in multiple myeloma treatment High costs and limited access make advanced cancer therapies unaffordable for many in India ...

(Image Credits: Pixabay) Immuneel Therapeutics on Monday launched Qartemi, a CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). According to the company’s statement, it is ...

Will further expand Galapagos’ manufacturing network in the U.S. for improved patient experience.

The company is leading the next wave of CAR-T cell therapy development using a multitargeted approach that can be leveraged for the treatment of both hematological malignancies and solid cancers.

Slovakia’s National Cancer Institute (NOÚ) is offering new hope to patients with otherwise incurable diagnoses, with the launch of innovative CAR T-cell therapy for lymphoma and leukaemia ...